PRP19 upregulation inhibits cell proliferation in lung adenocarcinomas by p21-mediated induction of cell cycle arrest.

Arko-Boham Benjamin, Xin Zhou, Okai Isaac, Haoqi Zhao, Yang Song, Xinming Chi, Bing Sun, Lihong Hao, Liyuan Zhang, Lu Liu, Hongwei Guan, Shujuan Shao
Author Information
  1. Arko-Boham Benjamin: Department of Histology and Embryology, Dalian Medical University, 9 Western Section, Lvshun South Road, Lvshunkou District, Dalian 116044, PR China; Liaoning Provincial Key Laboratory for Proteomics, Dalian Medical University, 9 Western Section, Lvshun South Road, Dalian 116044, PR China; School of Allied Health Sciences, University of Ghana, P. O. Box KB143, Accra, Ghana.
  2. Xin Zhou: Department of Histology and Embryology, Dalian Medical University, 9 Western Section, Lvshun South Road, Lvshunkou District, Dalian 116044, PR China; Liaoning Provincial Key Laboratory for Proteomics, Dalian Medical University, 9 Western Section, Lvshun South Road, Dalian 116044, PR China.
  3. Okai Isaac: Department of Histology and Embryology, Dalian Medical University, 9 Western Section, Lvshun South Road, Lvshunkou District, Dalian 116044, PR China; Liaoning Provincial Key Laboratory for Proteomics, Dalian Medical University, 9 Western Section, Lvshun South Road, Dalian 116044, PR China; Department of Anatomy, SMS, Kwame Nkrumah University of Science and Technology, PMB, Kumasi, Ghana.
  4. Haoqi Zhao: Department of Histology and Embryology, Dalian Medical University, 9 Western Section, Lvshun South Road, Lvshunkou District, Dalian 116044, PR China; Liaoning Provincial Key Laboratory for Proteomics, Dalian Medical University, 9 Western Section, Lvshun South Road, Dalian 116044, PR China.
  5. Yang Song: Department of Histology and Embryology, Dalian Medical University, 9 Western Section, Lvshun South Road, Lvshunkou District, Dalian 116044, PR China; Liaoning Provincial Key Laboratory for Proteomics, Dalian Medical University, 9 Western Section, Lvshun South Road, Dalian 116044, PR China.
  6. Xinming Chi: Department of Histology and Embryology, Dalian Medical University, 9 Western Section, Lvshun South Road, Lvshunkou District, Dalian 116044, PR China; Liaoning Provincial Key Laboratory for Proteomics, Dalian Medical University, 9 Western Section, Lvshun South Road, Dalian 116044, PR China.
  7. Bing Sun: Department of Chest Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, PR China.
  8. Lihong Hao: Department of Histology and Embryology, Dalian Medical University, 9 Western Section, Lvshun South Road, Lvshunkou District, Dalian 116044, PR China; Liaoning Provincial Key Laboratory for Proteomics, Dalian Medical University, 9 Western Section, Lvshun South Road, Dalian 116044, PR China.
  9. Liyuan Zhang: Liaoning Provincial Key Laboratory for Proteomics, Dalian Medical University, 9 Western Section, Lvshun South Road, Dalian 116044, PR China.
  10. Lu Liu: Liaoning Provincial Key Laboratory for Proteomics, Dalian Medical University, 9 Western Section, Lvshun South Road, Dalian 116044, PR China.
  11. Hongwei Guan: Department of Pathology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, PR China.
  12. Shujuan Shao: Department of Histology and Embryology, Dalian Medical University, 9 Western Section, Lvshun South Road, Lvshunkou District, Dalian 116044, PR China; Liaoning Provincial Key Laboratory for Proteomics, Dalian Medical University, 9 Western Section, Lvshun South Road, Dalian 116044, PR China. Electronic address: shaoshujuan2006@126.com.

Abstract

Precursor messenger RNA processing factor 19 (PRP19) is known to be a critical component of the eukaryotic spliceosomal machinery and DNA damage repair system, the deregulation of which leads to many disease conditions. In many human cancers, PRP19 expression is upregulated, but its functional significance and corresponding underlying mechanisms remain to be addressed. Focusing on lung carcinomas, PRP19 upregulation was achieved by plasmid transfection into A549 adenocarcinoma cells. The transfected cells were then subjected to several in vitro and in vivo assays following in situ assessment of the protein in paired clinical lung tissues. We report that PRP19 expression is elevated in lung carcinoma tissues compared to non-tumor tissues. Following its upregulation, PRP19 repressed cell proliferation and tumor growth by upregulating the expression of the cell cycle arrest protein p21.

Keywords

MeSH Term

Adenocarcinoma
Adenocarcinoma of Lung
Animals
Cell Cycle Checkpoints
Cell Line, Tumor
Cell Proliferation
Cyclin-Dependent Kinase Inhibitor p21
DNA Repair Enzymes
Gene Expression Regulation, Neoplastic
Humans
Lung Neoplasms
Mice
Mice, Inbred BALB C
Mice, Nude
Nuclear Proteins
RNA Splicing Factors
Transfection
Up-Regulation

Chemicals

Cyclin-Dependent Kinase Inhibitor p21
Nuclear Proteins
RNA Splicing Factors
DNA Repair Enzymes
PRPF19 protein, human

Word Cloud

Created with Highcharts 10.0.0PRP19lungcellexpressionupregulationtissuesproliferationmanycellsproteincarcinomacyclearrestp21PrecursormessengerRNAprocessingfactor19knowncriticalcomponenteukaryoticspliceosomalmachineryDNAdamagerepairsystemderegulationleadsdiseaseconditionshumancancersupregulatedfunctionalsignificancecorrespondingunderlyingmechanismsremainaddressedFocusingcarcinomasachievedplasmidtransfectionA549adenocarcinomatransfectedsubjectedseveralvitrovivoassaysfollowingsituassessmentpairedclinicalreportelevatedcomparednon-tumorFollowingrepressedtumorgrowthupregulatinginhibitsadenocarcinomasp21-mediatedinductionCellLung

Similar Articles

Cited By (7)